Maxime Paris


Dr. Maxime Paris is the founder and CEO of EXKA, a leader in cannabis genetics, micropropagation and extraction. Prior to founding EXKA, Max was a Research Associate at the Western Australian State Agricultural Biotechnology Centre (SABC), where he developed and supervised a plant genetic screening program and was an Executive Director at CIBC World Markets, where he namely held the role of equity analyst covering healthcare, pharmaceuticals & biotechnology. Dr. Paris holds a PhD in Plant Molecular Genetics from Murdoch University (Western Australia), where he focused on the development of high-throughput genotyping methods for marker-assisted plant breeding, an MBA from HEC Montreal and a B.Sc. in Botanical Sciences from McGill University.